Innovation Leader, Diego Miralles, M.D., Joins Adaptive Biotechnologies As President Of Adaptive Therapeutics

Adaptive Biotechnologies, the leader in next generation sequencing (NGS) and expert bioinformatics to profile T- and B-cell receptors of the adaptive immune system, announces the appointment of Diego Miralles, M.D., as President of Adaptive Therapeutics. Most recently Dr. Miralles was the Global Head, Johnson & Johnson Innovation, where he established the Johnson & Johnson Innovation Centers, JLABS, and Janssen Healthcare Innovation. Dr. Miralles will build the Therapeutics Division of Adaptive, and head the Company’s efforts to leverage its best-in-class platform for identifying T- and B-cell receptors for use in therapies that will directly impact . . .